The effect of NAOs on HFD-induced obese mice effectively suppressed obesity and metabolic diseases associated with obesity (hyperlipidemia, steatosis, insulin resistance, and glucose intolerance) through increased adiponectin production and regulation of the gut microbiome. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.